The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling
- PMID: 29475939
- PMCID: PMC5900773
- DOI: 10.1074/jbc.RA117.001194
The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling
Abstract
Aberrant cell surface glycosylation is prevalent in tumor cells, and there is ample evidence that glycans have functional roles in carcinogenesis. Nonetheless, many molecular details remain unclear. Tumor cells frequently exhibit increased α2-6 sialylation on N-glycans, a modification that is added by the ST6Gal-I sialyltransferase, and emerging evidence suggests that ST6Gal-I-mediated sialylation promotes the survival of tumor cells exposed to various cell stressors. Here we report that ST6Gal-I protects cancer cells from hypoxic stress. It is well known that hypoxia-inducible factor 1α (HIF-1α) is stabilized in hypoxic cells, and, in turn, HIF-1α directs the transcription of genes important for cell survival. To investigate a putative role for ST6Gal-I in the hypoxic response, we examined HIF-1α accumulation in ovarian and pancreatic cancer cells in ST6Gal-I overexpression or knockdown experiments. We found that ST6Gal-I activity augmented HIF-1α accumulation in cells grown in a hypoxic environment or treated with two chemical hypoxia mimetics, deferoxamine and dimethyloxalylglycine. Correspondingly, hypoxic cells with high ST6Gal-I expression had increased mRNA levels of HIF-1α transcriptional targets, including the glucose transporter genes GLUT1 and GLUT3 and the glycolytic enzyme gene PDHK1 Interestingly, high ST6Gal-I-expressing cells also had an increased pool of HIF-1α mRNA, suggesting that ST6Gal-I may influence HIF-1α expression. Finally, cells grown in hypoxia for several weeks displayed enriched ST6Gal-I expression, consistent with a pro-survival function. Taken together, these findings unravel a glycosylation-dependent mechanism that facilitates tumor cell adaptation to a hypoxic milieu.
Keywords: ST6Gal-I; anoxia; cancer stem cells; cell stress; cell surface glycosylation; glycan; glycosylation; hypoxia; hypoxia-inducible factor (HIF); sialyltransferase.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.
Conflict of interest statement
The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health
Figures
Similar articles
-
ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.J Biol Chem. 2018 Feb 2;293(5):1610-1622. doi: 10.1074/jbc.M117.801480. Epub 2017 Dec 12. J Biol Chem. 2018. PMID: 29233887 Free PMC article.
-
Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.Acta Biochim Pol. 2006;53(4):789-99. Epub 2006 Dec 4. Acta Biochim Pol. 2006. PMID: 17143338
-
Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover.J Biol Chem. 2020 Oct 9;295(41):14153-14163. doi: 10.1074/jbc.RA120.014887. Epub 2020 Aug 6. J Biol Chem. 2020. PMID: 32763973 Free PMC article.
-
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.Molecules. 2015 Apr 24;20(5):7509-27. doi: 10.3390/molecules20057509. Molecules. 2015. PMID: 25919275 Free PMC article. Review.
-
Regulation of Cancer-Associated miRNAs Expression under Hypoxic Conditions.Anal Cell Pathol (Amst). 2024 May 10;2024:5523283. doi: 10.1155/2024/5523283. eCollection 2024. Anal Cell Pathol (Amst). 2024. PMID: 38766303 Free PMC article. Review.
Cited by
-
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.J Ovarian Res. 2019 Oct 14;12(1):93. doi: 10.1186/s13048-019-0574-5. J Ovarian Res. 2019. PMID: 31610800 Free PMC article.
-
ST6GAL1: A key player in cancer.Oncol Lett. 2019 Aug;18(2):983-989. doi: 10.3892/ol.2019.10458. Epub 2019 Jun 7. Oncol Lett. 2019. PMID: 31423157 Free PMC article. Review.
-
ST6Gal1: Oncogenic signaling pathways and targets.Front Mol Biosci. 2022 Aug 29;9:962908. doi: 10.3389/fmolb.2022.962908. eCollection 2022. Front Mol Biosci. 2022. PMID: 36106023 Free PMC article. Review.
-
Gene expression and DNA methylation changes in response to hypoxia in toxicant-adapted Atlantic killifish (Fundulus heteroclitus).bioRxiv [Preprint]. 2024 Nov 2:2024.11.01.620405. doi: 10.1101/2024.11.01.620405. bioRxiv. 2024. Update in: Biol Open. 2025 Jan 15;14(1):BIO061801. doi: 10.1242/bio.061801 PMID: 39554046 Free PMC article. Updated. Preprint.
-
Inhibition of galectins in cancer: Biological challenges for their clinical application.Front Immunol. 2023 Jan 10;13:1104625. doi: 10.3389/fimmu.2022.1104625. eCollection 2022. Front Immunol. 2023. PMID: 36703969 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
